| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2023 |
4
| Sorrento Therapeutics, Inc. (10% Owner) has filed a Form 4 on Celularity Inc|
Txns:
| Sold 9,064,539 shares
@ $0
Sold 6,307,158 shares
@ $0 |
|
| 07/19/2023 |
4
| Kilcoyne Adrian (Chief Medical Officer) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 875,000 shares
@ $0 |
|
| 06/30/2023 |
4/A
| Lim Kok Thay (Director) has filed a Form 4 on Celularity Inc|
Txns:
| Paid exercise price by delivering 10,844 shares
@ $0.7503, valued at
$8.1k
|
|
| 06/16/2023 |
4
| Parks Diane L. (Director) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 199,921 shares
@ $0
Granted 277,778 options to buy
@ $0.7503, valued at
$208.4k
|
|
| 06/16/2023 |
4
| Kehler Dean C (Director) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 199,921 shares
@ $0
Granted 277,778 options to buy
@ $0.7503, valued at
$208.4k
|
|
| 06/16/2023 |
4
| Smith Robin L (Director) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 199,921 shares
@ $0
Granted 277,778 options to buy
@ $0.7503, valued at
$208.4k
|
|
| 06/16/2023 |
4
| Mazur Marc (Director) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 199,921 shares
@ $0
Granted 277,778 options to buy
@ $0.7503, valued at
$208.4k
|
|
| 06/16/2023 |
4
| VON ESCHENBACH ANDREW C. (Director) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 199,921 shares
@ $0
Granted 277,778 options to buy
@ $0.7503, valued at
$208.4k
|
|
| 06/16/2023 |
4
| SCULLEY JOHN (Director) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 199,921 shares
@ $0
Granted 277,778 options to buy
@ $0.7503, valued at
$208.4k
|
|
| 06/16/2023 |
4
| Diamandis Peter (Director) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 199,921 shares
@ $0
Granted 277,778 options to buy
@ $0.7503, valued at
$208.4k
|
|
| 06/16/2023 |
4
| Lim Kok Thay (Director) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 199,921 shares
@ $0
Granted 277,778 options to buy
@ $0.7503, valued at
$208.4k
|
|
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2023 |
4
| Fletcher Kyle (See Remarks) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 225,000 shares
@ $0 |
|
| 02/22/2023 |
4
| Haines John R (Senior Exec Vice President) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 400,000 shares
@ $0 |
|
| 02/22/2023 |
4
| Beers David C (CFO) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 250,000 shares
@ $0 |
|
| 02/22/2023 |
4
| Glover Bradley (See Remarks) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 300,000 shares
@ $0 |
|
| 02/22/2023 |
4
| Brigido Stephen (Pres, Functional Regeneration) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 200,000 shares
@ $0 |
|
| 02/22/2023 |
4
| Kilcoyne Adrian (Chief Medical Officer) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 300,000 shares
@ $0 |
|
| 02/14/2023 |
4
| Diamandis Peter (Director) has filed a Form 4 on Celularity Inc|
Txns:
| Exercised 1,071,000 options to buy
@ $0.28, valued at
$299.9k
|
|
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2022 |
4
| Kilcoyne Adrian (See Remarks) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 66,226 options to buy
@ $2.19, valued at
$145k
|
|
| 10/04/2022 |
3
| Kilcoyne Adrian (See Remarks) has filed a Form 3 on Celularity Inc |
|